A detailed history of Sonora Investment Management Group, LLC transactions in Intra Cellular Therapies, Inc. stock. As of the latest transaction made, Sonora Investment Management Group, LLC holds 87,884 shares of ITCI stock, worth $7.3 Million. This represents 0.55% of its overall portfolio holdings.

Number of Shares
87,884
Previous 87,430 0.52%
Holding current value
$7.3 Million
Previous $5.99 Million 7.31%
% of portfolio
0.55%
Previous 0.54%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

BUY
$67.99 - $80.84 $30,867 - $36,701
454 Added 0.52%
87,884 $6.43 Million
Q1 2024

May 13, 2024

SELL
$64.37 - $75.65 $5,471 - $6,430
-85 Reduced 0.1%
87,430 $6.05 Million
Q4 2023

Feb 14, 2024

SELL
$46.37 - $73.65 $15,209 - $24,157
-328 Reduced 0.37%
87,515 $6.27 Million
Q3 2023

Nov 02, 2023

SELL
$52.09 - $64.1 $17,398 - $21,409
-334 Reduced 0.38%
87,843 $4.58 Million
Q2 2023

Aug 10, 2023

SELL
$54.67 - $66.44 $159,581 - $193,938
-2,919 Reduced 3.2%
88,177 $5.58 Million
Q1 2023

May 12, 2023

SELL
$43.8 - $56.99 $47,085 - $61,264
-1,075 Reduced 1.17%
91,096 $4.93 Million
Q4 2022

Feb 13, 2023

BUY
$44.07 - $54.45 $95,940 - $118,537
2,177 Added 2.42%
92,171 $4.88 Million
Q3 2022

Nov 03, 2022

BUY
$42.7 - $59.99 $6,405 - $8,998
150 Added 0.17%
89,994 $5.14 Million
Q2 2022

Aug 15, 2022

SELL
$43.0 - $65.64 $30,100 - $45,948
-700 Reduced 0.77%
89,844 $5.13 Million
Q1 2022

May 12, 2022

BUY
$38.74 - $62.09 $57,838 - $92,700
1,493 Added 1.68%
90,544 $5.54 Million
Q4 2021

Feb 11, 2022

BUY
$35.2 - $53.42 $3.13 Million - $4.76 Million
89,051 New
89,051 $4.66 Million

Others Institutions Holding ITCI

About Intra-Cellular Therapies, Inc.


  • Ticker ITCI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 94,401,696
  • Market Cap $7.85B
  • Description
  • Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...
More about ITCI
Track This Portfolio

Track Sonora Investment Management Group, LLC Portfolio

Follow Sonora Investment Management Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sonora Investment Management Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sonora Investment Management Group, LLC with notifications on news.